Price T Rowe Associates Inc Kodiak Sciences Inc. Transaction History

Price T Rowe Associates Inc

$867 Billion
Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,268,509 shares of KOD stock, worth $6.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,268,509

Previous 11,446 10982.55%

Holding current value

$6.47 Million

Previous $30,000 41973.33%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$2.6 - $10.9 $3.27 Million - $13.7 Million	1,257,063 Added 10982.55%	1,268,509 $12.6 Million
Q3 2024 Nov 14, 2024	BUY	$2.2 - $3.25 $25,181 - $37,199	11,446 New	11,446 $30,000
Q2 2023 Aug 14, 2023	BUY	$4.3 - $9.48 $2.13 Million - $4.69 Million	494,463 New	494,463 $3.41 Million
Q4 2022 Feb 14, 2023	SELL	$6.52 - $8.05 $1.79 Million - $2.21 Million	-273,966 Reduced 36.73%	472,013 $3.38 Million
Q3 2022 Nov 14, 2022	BUY	$7.57 - $12.5 $677,976 - $1.12 Million	89,561 Added 13.64%	745,979 $5.77 Million
Q2 2022 Aug 15, 2022	SELL	$5.04 - $9.48 $139,759 - $262,880	-27,730 Reduced 4.05%	656,418 $5.02 Million
Q1 2022 May 16, 2022	SELL	$7.09 - $89.45 $52.7 Million - $665 Million	-7,432,314 Reduced 91.57%	684,148 $5.28 Million
Q4 2021 Feb 14, 2022	BUY	$80.85 - $128.49 $4.87 Million - $7.74 Million	60,232 Added 0.75%	8,116,462 $688 Million
Q3 2021 Nov 15, 2021	BUY	$81.97 - $106.94 $52.7 Million - $68.8 Million	643,080 Added 8.67%	8,056,230 $773 Million
Q2 2021 Aug 16, 2021	BUY	$77.2 - $126.54 $42.6 Million - $69.8 Million	551,429 Added 8.04%	7,413,150 $689 Million
Q1 2021 May 17, 2021	BUY	$110.45 - $164.47 $75.7 Million - $113 Million	685,510 Added 11.1%	6,861,721 $778 Million
Q4 2020 Feb 16, 2021	BUY	$60.78 - $154.03 $375 Million - $951 Million	6,176,211 New	6,176,211 $907 Million

Others Institutions Holding KOD

# of Institutions

110

Shares Held

40.9M

Call Options Held

13.8K

Put Options Held

5.8K

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $265M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Kodiak Sciences Inc. Transaction History